1 in 10 patients taking Wegovy and Ozempic lose less than 5 per cent of body weight despite high expectations

An estimated one in 50 UK adults now use fat jabs with demand soaring since 2023 when the National Institute for Health and Care Excellence (Nice) approved Wegovy for weight loss on the NHS.


6 d.
Science
ID: -8403979693477962076


Similar News expand_more


Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Education
Culture
Science
Science
Science
Science
Science
Science
Science
Automotive
Science
Science
Science
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down